copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - agenti antineoplastici - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
claritromicina eg
eg s.p.a. - claritromicina - claritromicina
claritromicina mylan generics
mylan s.p.a. - claritromicina - claritromicina
claritromicina sun pharmaceutical industries limited
sun pharmaceutical industries (europe) b.v. - claritromicina - claritromicina
claritromicina teva
teva italia s.r.l. - claritromicina - claritromicina
claritromicina sun pharma
sun pharmaceutical industries (europe) b.v. - claritromicina - claritromicina
claritromicina alter
laboratori alter s.r.l. - claritromicina - claritromicina
claritromicina sandoz
sandoz s.p.a. - claritromicina - claritromicina
claritromicina pensa
towa pharmaceutical s.p.a. - claritromicina - claritromicina
claritromicina doc generici
doc generici srl - claritromicina - claritromicina